Therapeutic Immunoglobulin Selected For High Antibody Titer to RSV Also Contains High Antibody Titers to Other Respiratory Viruses

Therapeutic Immunoglobulin Selected For High Antibody Titer to RSV Also Contains High Antibody Titers to Other Respiratory Viruses

Specific antibodies against infections most relevant to patients with primary immunodeficiency diseases (PIDD) are not routinely evaluated in commercial polyclonal immunoglobulin preparations. A polyclonal immunoglobulin prepared from plasma of donors having high neutralizing antibody titers to res...

Full description

Bibliographic Details
Main Author:	Jordan eOrange
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-08-01
Series:	Frontiers in Immunology
Subjects:	RSV IVIg respiratory viruses immune deficiency hyperimmune globulin
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00431/full

Similar Items

In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors
by: Gabriel Rojas-Jiménez, et al.
Published: (2022-01-01)

HCMV Infection of Human Trophoblast Progenitor Cells of the Placenta Is Neutralized by a Human Monoclonal Antibody to Glycoprotein B and Not by Antibodies to the Pentamer Complex
by: Martin Zydek, et al.
Published: (2014-03-01)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
by: Li He, et al.
Published: (2022-07-01)

Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence
by: Luigi Brunetti, et al.
Published: (2023-02-01)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
by: Stephan von Gunten, et al.
Published: (2023-03-01)

Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)—Specific Monoclonal Antibodies
by: Lotte Jacobs, et al.
Published: (2023-09-01)

Effect of domperidone (leisguard®) on antibody titers, inflammatory markers and creatinine in dogs with leishmaniosis and chronic kidney disease
by: Maria Alfonsa Cavalera, et al.
Published: (2021-10-01)

Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report
by: Mafalda De Rienzo, et al.
Published: (2021-08-01)

Hyperimmune Globulins for the Management of Infectious Diseases
by: Ilaria Pati, et al.
Published: (2023-07-01)

Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
by: Sara A. Taleb, et al.
Published: (2021-08-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia
by: Hessa A. Al-Sharif, et al.
Published: (2020-11-01)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
by: Elena E. Perez, et al.
Published: (2021-07-01)

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
by: Kathrin Endt, et al.
Published: (2022-06-01)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
by: Thomas Rogier, et al.
Published: (2020-06-01)

Detection of impaired IgG antibody formation facilitates the decision on early immunoglobulin replacement in hypogammaglobulinemic patients
by: Hermann Maximilian Wolf, et al.
Published: (2015-02-01)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
by: Moritz B. Immohr, et al.
Published: (2021-12-01)

Pneumococcal Antibody Titers
by: Pamella F. Abghari MD, et al.
Published: (2017-02-01)

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-06-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
by: Lori M. Cullen, et al.
Published: (2017-12-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
by: Morgan D. McSweeney, et al.
Published: (2024-03-01)

Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV
by: Akihito Sawada, et al.
Published: (2021-02-01)

Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy
by: Giovanni Nigro, et al.
Published: (2023-06-01)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
by: Melissa Panesso, et al.
Published: (2023-07-01)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
by: Ruklanthi de Alwis, et al.
Published: (2020-05-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

RSV infection and recurrence of respiratory tract obstruction in children
by: Karolina Kapusta, et al.
Published: (2016-06-01)

Analysis of specific IgG titres against tick borne encephalitis in patients with primary antibody deficiency under immunoglobulin substitution therapy: impact of plasma donor origin
by: Sigune eGoldacker, et al.
Published: (2015-01-01)

RSV Disease Threat and Innovative Prevention Methods in Health Protection: A Review
by: Paulina Dąbrowska, et al.
Published: (2024-02-01)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
by: Jackelyn Murray, et al.
Published: (2022-04-01)

Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein
by: Wayne Harshbarger, et al.
Published: (2021-01-01)

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
by: Brian M. Maas, et al.
Published: (2021-11-01)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
by: Jintanat Ananworanich, et al.
Published: (2021-08-01)

Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States
by: Mark H. Rozenbaum, et al.
Published: (2023-01-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

RSV awareness, risk perception, causes, and terms: Comment
by: Somsri Wiwanitkit, et al.
Published: (2023-12-01)

Do Australian immunoglobulin products meet international measles antibody titer standards?
by: Megan K. Young, et al.
Published: (2017-03-01)